What would happen to rates of infection with hepatitis C if we closed down all the needle exchanges? Research has established that needle/syringe programmes are a cost-effective way to reduce spread of HIV, but just two studies have considered the same issue in relation to hepatitis C.
In three UK municipalities, the answers were predicted to be more infections, lost low-cost opportunities to improve and save lives, and in two of the areas, greater health-related costs overall. Conclusion was that these services are among the best investments UK health services can make.
The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and opioid substitution therapy, rather than a reduction in the number of people with hepatitis C as a result of increased treatment of HCV infection, a modelling study published in the journal Addiction reports.
Researchers from the University of Bristol and three Scottish universities developed a model of the Scottish HCV epidemic to test the impact of varying levels of harm reduction provision.
Hepatitis SA invites you to The 2018 HepLINK Forum: Engaging Marginalised Populations in Hepatitis C Treatment
Thjis will be held on Thursday, 1 March, 11am–2pm (lunch provided), at the Education Development Centre (EDC), 4 Milner St, Hindmarsh.
Keynote speaker: Dr Phillip Read, Director, Kirketon Road Centre
Dr Phillip Read is a sexual health physician and the Director of the Kirketon Road Centre in Sydney’s Kings Cross. Kirketon Road is a primary health care facility involved in the prevention, treatment and care of HIV, hepatitis and STIs among people who inject drugs, sex workers and at-risk young people.
Rosalie Altus, Practice Consultant Viral Hepatitis Liaison Nurse, Flinders Medical Centre
Panel discussion with guest speakers representing the Aboriginal, youth, regional, multicultural and CNP sectors across South Australia
From 1 January 2018, Mission Australia Hindmarsh Centre after-hours Clean Needle Program (CNP) service component (Monday to Friday 5pm to 8pm) will discontinue. However, the daytime CNP service at the Hindmarsh Centre, provided by Hepatitis SA staff will continue Monday to Friday 1.30pm to 5.00pm, with syringe vending machine services available 24 hours per day 7 days per week until 30 June 2018.
The following expanded after-hours CNP service options will become available to clients in the Adelaide metropolitan area in October and November 2017:
NEW Uniting Communities Hendon CNP service details – opening Monday 9th October 2017:
45-47 Tapleys Hill Rd, Hendon (ph) 8202 5610
After-hours CNP service Monday to Sunday 5.00pm to 12.00am (midnight).
Daytime CNP service Monday to Sunday 9.00am to 5.00pm.
1 x syringe vending machine available 24 hrs per day 7 days per week from mid-October onwards
NEW Thursday night DASSA Central Stepney after-hours CNP service details – opening Thursday 16th November 2017:
91 Magill Rd, Stepney (ph) 7245 5080
After hours CNP service Thursdays only 5.00pm to 9.00pm
Daytime CNP service Monday to Friday 9.00am to 5.00pm
2 x syringe vending machines available 24hrs per day 7 days per week.
Syringe vending machines continue to be available 24hr per day 7 days per week at the following locations in SA:
NORTH – DASSA Northern Service, 22 Langford Drive, ELIZABETH.
SOUTH – Noarlunga Health Village, Alexander Kelly Drive, NOARLUNGA
EAST – DASSA Central Service, 91 Magill Rd, STEPNEY
WEST – Hindmarsh Centre, 35 Richards St, HINDMARSH.
Free community CNP sites across South Australia:
For a complete list of all free community CNP sites across South Australia, type “Clean Needle Program SA” into the Google search bar and then click on the link for “Clean Needle Program Sites List – SA Health”.
OR call the Alcohol and Drug Information Service (ADIS) on 1300 131 340
For further information:
Please contact the Clean Needle Program by phoning (08) 7425 5080
6th International Symposium on Hepatitis Care in Substance Users, 6th Sept 2017
An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.
“The number of people around the world dying from hepatitis C is increasing. We have the tools to reverse this trend, to eliminate this disease and save millions of lives. But it will not happen until people who use drugs become a focus of our efforts,” said Associate Professor Jason Grebely, President of the International Network of Hepatitis C in Substance Users (INHSU), the convenors of the conference.